VIRI - virios.com Operating income before deduction of amortization

Virios Therapeutics evolved through a merger with a vaccine developer to integrate research capabilities. The positive trend in EBITDA confirms the success of the IMC-1 therapy against fibromyalgia and long COVID. Growth potential is based on FDA approvals and distribution contracts, while the indicator remains at , demonstrating the business's current cash strength.

VIRI - Virios Therapeutics Inc. Operating profit before deduction of amortization over the range 07/04/2022 - 11/14/2026

Virios Therapeutics, Inc. - analytical breakdowns and key metrics (VIRI)

- stock price and consensus target price:

Price Chart Virios Therapeutics Inc.|VIRI - Analyst Consensus Forecast

- market capitalization statistics:

Market Capitalization Virios Therapeutics|VIRI - Total Company Value

- balance sheet equity data:

Accounting Value of a Share Virios Therapeutics|VIRI - Company Net Assets|Market Capitalization to Book Value Ratio virios.com|VIRI - Aggregate Company Assets

- debt level and financial liquidity data:

Total Debt to Capital Coefficient Virios Therapeutics|VIRI - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Virios Therapeutics Inc.|VIRI - Company Aggregate Debts|Debts to Net Assets Virios Therapeutics|VIRI - Company Long-Term Debt|Company Short-Term Loans and Borrowings Virios Therapeutics|Interim Coverage Ratio virios.com

- earnings and market ratios statistics:

VIRI - Company Net Income|Expected Net Profit Virios Therapeutics|VIRI - Price to Earnings Ratio|Market Cap to Projected Earnings Virios Therapeutics Inc.|VIRI - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Virios Therapeutics|VIRI - Operating profit before deduction of amortization|Earnings per share for the last four quarters Virios Therapeutics|VIRI - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months virios.com|VIRI - Earnings growth in current year|Expected net earnings per share growth next year Virios Therapeutics

- sales and revenue indicators:

VIRI - Company Revenue|Company Future Revenue Virios Therapeutics Inc.|VIRI - P/S Multiple|Forward P/S Multiple Virios Therapeutics

Summary company analytics:VIRI Virios Therapeutics

Signature product of Virios Therapeutics Inc.

Professional selection of sustainable assets requires an analysis of operational efficiency excluding debt load and depreciation. This absolute cash result of operations measures the net cash flow from operating activities, where for Virios Therapeutics (VIRI) the stability of this metric confirms the success of laboratory modernization and the implementation of digital trial monitoring under strict environmental control.

Competitors of Virios Therapeutics (VIRI)